United States //   News Releases

News Releases

News Releases

Date Title and Summary Additional Formats
Toggle Summary FOUR-YEAR ITALIAN COMPARATIVE STUDY SUPPORTS ENDOLOGIX Powerlink SINGLE-PIECE DESIGN
FOUR-YEAR ITALIAN COMPARATIVE STUDY SUPPORTS ENDOLOGIX Powerlink SINGLE-PIECE DESIGN Study Data to be Presented at the International Congress Conference Irvine, Calif. - February 11, 2004 - Endologix, Inc. (Nasdaq: ELGX) today announced that data from a four-year retrospective comparative Italian
View HTML
Toggle Summary ENDOLOGIX TO HOST CONFERENCE CALL TO DISCUSS DEVELOPMENT AGREEMENT FOR BIOFOAM
ENDOLOGIX TO HOST CONFERENCE CALL TO DISCUSS DEVELOPMENT AGREEMENT FOR BIOFOAM IRVINE, Calif. (January 10, 2004) - Endologix, Inc. (Nasdaq: ELGX) will host a conference call tomorrow, Tuesday, January 11, 2005 at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time) to discuss the details of its
View HTML
Toggle Summary ENDOLOGIX SUBMITS Powerlink PMA TO THE FDA
Irvine, Calif. – January 8, 2004 – Endologix, Inc. (Nasdaq: ELGX) today announced it has filed its completed pre-market approval (PMA) submission with the U.S. Food and Drug Administration (FDA) for the Powerlink® System, an endoluminal stent graft (ELG) for the minimally invasive
View HTML